Natalizumab reduces loss of visual function in patients with relapsing multiple sclerosis

被引：0
|
作者：
Balcer, L
Galetta, SL
O'Connor, PW
Havrdova, E
Hutchinson, M
Kappos, L
Miller, DH
Phillips, JT
Polman, CH
Stuart, WH
Calabresi, PA
Confavreux, C
Radue, EW
Rudick, RA
Lublin, FD
Giovannoni, G
Wajgt, A
Weinstock-Guttman, B
Wynn, DR
Lynn, FA
Panzara, MA
Sandrock, AW
机构：
来源：
NEUROLOGY | 2006年 / 66卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A251 / A251
页数：1
相关论文
共 50 条
  • [1] Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
    Balcer, L. J.
    Galetta, S. L.
    Calabresi, P. A.
    Confavreux, C.
    Giovannoni, G.
    Havrdova, E.
    Hutchinson, M.
    Kappos, L.
    Lublin, F. D.
    Miller, D. H.
    O'Connor, P. W.
    Phillips, J. T.
    Polman, C. H.
    Radue, E.-W.
    Rudick, R. A.
    Stuart, W. H.
    Wajgt, A.
    Weinstock-Guttman, B.
    Wynn, D. R.
    Lynn, F.
    Panzara, M. A.
    NEUROLOGY, 2007, 68 (16) : 1299 - 1304
  • [2] Natalizumab reduces visual loss in patiens with relapsing multiple sclerosis
    Stourac, Pavel
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2007, 70 (04) : 419 - 419
  • [3] Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patients
    Berkovich, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S154 - S155
  • [4] Natalizumab reduces cortical pathology in relapsing–remitting multiple sclerosis
    Nature Reviews Neurology, 2012, 8 (7) : 355 - 355
  • [5] NATALIZUMAB REDUCES RELAPSE-ASSOCIATED COSTS OF HOSPITALIZATIONS IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
    O'Day, K.
    Meyer, K.
    Rajagopalan, K.
    VALUE IN HEALTH, 2008, 11 (06) : A605 - A605
  • [6] Natalizumab for relapsing multiple sclerosis
    Tenser, RB
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (22): : 2387 - 2387
  • [7] The effects of natalizumab on a test of cognitive function in patients with relapsing multiple sclerosis (MS)
    Havrdova, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 307 - 307
  • [8] Alemtuzumab for patients with relapsing multiple sclerosis after Natalizumab
    Pena Martinez, J.
    Lopez Real, A. M.
    Oterino Duran, A.
    Costa Arpin, E.
    Gonzalez Suarez, I.
    Fernandez Fernandez, E.
    Rodriguez Regal, A.
    Solar Sanchez, D. M.
    Garcia Estevez, D. A.
    Rodriguez Rodriguez, M.
    Lorenzo Gonzalez, J. R.
    Prieto Gonzalez, J. M.
    Fernandez Uria, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 306 - 306
  • [9] The effects of natalizumab on disability progression as measured by the Multiple Sclerosis Functional Composite (MSFC) and visual function in patients with relapsing MS
    Galetta, SL
    O'Connor, PW
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, DH
    Phillips, JT
    Polman, CH
    Stuart, WH
    Calabresi, PA
    Confavreux, C
    Radue, EW
    Rudick, RA
    Lublin, FD
    Giovannoni, G
    Wajgt, A
    Weinstock-Guttinan, B
    Wynn, DR
    Balcer, L
    Lynn, F
    Toal, M
    Panzara, MA
    Sandrock, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S71 - S72
  • [10] Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab
    Sorensen, Per Soelberg
    Jensen, Poul Erik Hyldgaard
    Haghikia, Aiden
    Lundkvist, Malin
    Vedeler, Christian
    Sellebjerg, Finn
    Koch-Henriksen, Nils
    Fogdell-Hahn, Anna
    Myhr, Kjell-Morten
    Hillert, Jan
    Gold, Ralf
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (09) : 1074 - 1078
12345